• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

iNKT 细胞激动剂作为疫苗佐剂来对抗传染病。

iNKT cell agonists as vaccine adjuvants to combat infectious diseases.

机构信息

State Key Laboratory of Agricultural Microbiology, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan, Hubei, 430070, PR China.

Key Laboratory of Pesticide & Chemical Biology of Ministry of Education, Hubei International Scientific and Technological Cooperation Base of Pesticide and Green Synthesis, College of Chemistry, Central China Normal University, Wuhan, Hubei, 430079, PR China.

出版信息

Carbohydr Res. 2022 Mar;513:108527. doi: 10.1016/j.carres.2022.108527. Epub 2022 Feb 23.

DOI:10.1016/j.carres.2022.108527
PMID:35240551
Abstract

iNKT cells are a special type of T cell that acts as a link between the innate and adaptive immune systems, with the capacity to stimulate a wide range of cell types. The glycolipid α-galactosylceramide (αGC) is a robust agonist of iNKT cells and induces the secretion of Th1- and Th2-type cytokines. αGC and its analogs are widely used as adjuvants to enhance immune responses against viral, parasitic, and bacterial pathogens. This review first discusses the challenges of using free αGC as a vaccine adjuvant to treat infectious diseases. We next present strategies to realize the potential of the adjuvant effect of iNKT cell glycolipids, including (1) the use of Th1- or Th2-biasing αGC analogs, (2) covalent conjugation of glycolipid with antigen, (3) particulate vehicle-assisted delivery of glycolipid, (4) glycolipid-loaded cellular systems, (5) glycolipid combination with other immunostimulants, and (6) usage as mucosal adjuvants. Finally, we discuss future approaches for the development of iNKT cell agonists used as vaccine adjuvants against infectious diseases.

摘要

iNKT 细胞是一种特殊类型的 T 细胞,充当先天免疫和适应性免疫系统之间的桥梁,具有刺激多种细胞类型的能力。糖脂 α-半乳糖基神经酰胺(αGC)是 iNKT 细胞的有效激动剂,可诱导 Th1 和 Th2 型细胞因子的分泌。αGC 及其类似物被广泛用作佐剂,以增强针对病毒、寄生虫和细菌病原体的免疫反应。本综述首先讨论了使用游离 αGC 作为疫苗佐剂治疗传染病的挑战。接下来,我们提出了实现 iNKT 细胞糖脂佐剂作用潜力的策略,包括(1)使用偏向 Th1 或 Th2 的 αGC 类似物,(2)糖脂与抗原的共价偶联,(3)颗粒载体辅助糖脂递送,(4)负载糖脂的细胞系统,(5)糖脂与其他免疫刺激剂联合使用,以及(6)作为黏膜佐剂的使用。最后,我们讨论了开发用作传染病疫苗佐剂的 iNKT 细胞激动剂的未来方法。

相似文献

1
iNKT cell agonists as vaccine adjuvants to combat infectious diseases.iNKT 细胞激动剂作为疫苗佐剂来对抗传染病。
Carbohydr Res. 2022 Mar;513:108527. doi: 10.1016/j.carres.2022.108527. Epub 2022 Feb 23.
2
A New iNKT-Cell Agonist-Adjuvanted SARS-CoV-2 Subunit Vaccine Elicits Robust Neutralizing Antibody Responses.一种新型 iNKT 细胞激动剂佐剂的 SARS-CoV-2 亚单位疫苗可诱导强烈的中和抗体反应。
ACS Infect Dis. 2022 Oct 14;8(10):2161-2170. doi: 10.1021/acsinfecdis.2c00296. Epub 2022 Aug 31.
3
Glycolipid-Containing Nanoparticle Vaccine Engages Invariant NKT Cells to Enhance Humoral Protection against Systemic Bacterial Infection but Abrogates T-Independent Vaccine Responses.含神经节苷脂的纳米颗粒疫苗可激活固有自然杀伤 T 细胞,增强对全身细菌感染的体液保护,但会消除 T 细胞非依赖型疫苗应答。
J Immunol. 2021 Apr 15;206(8):1806-1816. doi: 10.4049/jimmunol.2001283.
4
Engaging Natural Killer T Cells as 'Universal Helpers' for Vaccination.利用自然杀伤 T 细胞作为疫苗接种的“通用助手”。
Drugs. 2017 Jan;77(1):1-15. doi: 10.1007/s40265-016-0675-z.
5
Glycolipid ligands of invariant natural killer T cells as vaccine adjuvants.作为疫苗佐剂的不变自然杀伤T细胞的糖脂配体
Expert Rev Vaccines. 2008 Dec;7(10):1519-32. doi: 10.1586/14760584.7.10.1519.
6
Endocytic pH regulates cell surface localization of glycolipid antigen loaded CD1d complexes.内吞作用的pH值调节负载糖脂抗原的CD1d复合物在细胞表面的定位。
Chem Phys Lipids. 2015 Oct;191:75-83. doi: 10.1016/j.chemphyslip.2015.08.010. Epub 2015 Aug 22.
7
NKT Cell-Driven Enhancement of Antitumor Immunity Induced by Clec9a-Targeted Tailorable Nanoemulsion.Clec9a 靶向定制化纳米乳介导的 NKT 细胞驱动的抗肿瘤免疫增强作用。
Cancer Immunol Res. 2019 Jun;7(6):952-962. doi: 10.1158/2326-6066.CIR-18-0650. Epub 2019 May 3.
8
Synergistic induction of adaptive antitumor immunity by codelivery of antigen with α-galactosylceramide on exosomes.外泌体共递送抗原和 α-半乳糖神经酰胺诱导适应性抗肿瘤免疫协同作用。
Cancer Res. 2013 Jul 1;73(13):3865-76. doi: 10.1158/0008-5472.CAN-12-3918. Epub 2013 May 8.
9
Tailored design of NKT-stimulatory glycolipids for polarization of immune responses.用于免疫反应极化的NKT刺激糖脂的定制设计。
J Biomed Sci. 2017 Mar 23;24(1):22. doi: 10.1186/s12929-017-0325-0.
10
Invariant natural killer T cells: innate-like T cells with potent immunomodulatory activities.不变自然杀伤T细胞:具有强大免疫调节活性的固有样T细胞。
Tissue Antigens. 2009 Jun;73(6):535-45. doi: 10.1111/j.1399-0039.2009.01256.x. Epub 2009 Apr 8.

引用本文的文献

1
The surveillance of viral infections by the unconventional Type I NKT cell.非常规I型自然杀伤T细胞对病毒感染的监测。
Front Immunol. 2024 Sep 17;15:1472854. doi: 10.3389/fimmu.2024.1472854. eCollection 2024.
2
NKT cells in the antitumor response: the β version?NKT 细胞在抗肿瘤反应中的作用:β 版本?
J Clin Invest. 2024 Feb 15;134(4):e177663. doi: 10.1172/JCI177663.
3
Natural Killer T Cell Diversity and Immunotherapy.自然杀伤T细胞多样性与免疫疗法
Cancers (Basel). 2023 Dec 7;15(24):5737. doi: 10.3390/cancers15245737.
4
Conformationally Restricted Analogues of α-Galactosylceramide as Adjuvant in COVID-19 Subunit Vaccine.α-半乳糖神经酰胺的构象受限类似物作为新冠病毒亚单位疫苗的佐剂
ACS Med Chem Lett. 2023 Nov 20;14(12):1647-1655. doi: 10.1021/acsmedchemlett.3c00154. eCollection 2023 Dec 14.
5
From design to clinic: Engineered peptide nanomaterials for cancer immunotherapy.从设计到临床:用于癌症免疫治疗的工程化肽纳米材料
Front Chem. 2023 Jan 17;10:1107600. doi: 10.3389/fchem.2022.1107600. eCollection 2022.
6
Efficient synthesis of α-galactosylceramide and its C-6 modified analogs.α-半乳糖神经酰胺及其C-6修饰类似物的高效合成
Front Chem. 2022 Nov 25;10:1039731. doi: 10.3389/fchem.2022.1039731. eCollection 2022.
7
Diversity-Oriented Synthesis of a Molecular Library of Immunomodulatory α-Galactosylceramides with Fluorous-Tag-Assisted Purification and Evaluation of Their Bioactivities in Regard to IL-2 Secretion.具有氟标记辅助纯化的免疫调节 α-半乳糖神经酰胺分子文库的多样性导向合成及其对 IL-2 分泌生物活性的评价。
Int J Mol Sci. 2022 Nov 2;23(21):13403. doi: 10.3390/ijms232113403.
8
Use of a MAIT-Activating Ligand, 5-OP-RU, as a Mucosal Adjuvant in a Murine Model of O1 Vaccination.在O1疫苗接种的小鼠模型中,使用MAIT激活配体5-OP-RU作为黏膜佐剂。
Pathog Immun. 2022 Aug 24;7(1):122-144. doi: 10.20411/pai.v7i1.525. eCollection 2022.